Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123317) titled 'Bioequivalence Study of Baloxavir Marboxil Tablets in Humans' on April 23.
Study Type: Interventional study
Study Design:
Cross-over
Primary Sponsor: The First Affiliated Hospital of Guilin Medical University
Condition:
Influenza
Intervention:
The fasting group:Period 1: Study participants were admitted to the clinical research ward 2 days prior to drug administration. They were required to fast for at least 8 hours before dosing. On the trial day, each participant received a single oral dose of either the test formulation or the reference formulation (1 tablet, 20 mg) after an overnight fast, with 240 mL of...